Christopher Bergeron, MD
Otolaryngology · la Jolla, CANPI 1508851775
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $47,099 of the $62,971 with a category attached, or 74.8%. Stryker accounts for 79.6% of it on its own, with 17 other manufacturers making up the rest. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $428.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$50K
- Regeneron$5K
- Optinose US, Inc.$4K
- Sanofi$2K
- Integra Lifesciences Corporation$654
- Medtronic$239
- plus $845 from 12 others
What the payments were for
- Consulting fees$47,09975%
- Speaking & faculty fees$2,5004%
- Travel & lodging$8,38413%
- Food & beverage$4,7418%
- Education$240%
- Other$2220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 87 | $50,097 |
| Regeneron | 3 | $5,036 |
| Optinose US, Inc. | 21 | $3,885 |
| Sanofi | 4 | $2,216 |
| Integra Lifesciences Corporation | 9 | $654 |
| Medtronic(2 entities) | 5 | $239 |
| Acclarent, Inc | 4 | $210 |
| Amgen | 1 | $194 |
| KARL Storz Endoscopy-america | 3 | $151 |
| AstraZeneca | 1 | $67 |
| Neurent Medical Limited | 2 | $54 |
| Brainlab, Inc. | 1 | $41 |
| GSK | 1 | $33 |
| AMAG Pharmaceuticals, Inc. | 1 | $24 |
| Acera Surgical, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$28,259
- XPRESS ENT DILATION SYSTEM$10,514
- TGS GUIDEWIRE$9,988
- CORE$9,577
- DUPIXENT$7,043
- NEPTUNE$5,100
- Xhance$3,306
- XPRESS LOPROFILE$2,338
- LATERA$1,700
- FOCESS$1,488
- NASOPORE$1,488
- N/A$425
- CLARIFIX CRYOTHERAPY DEVICE$276
- Acclarent Aera$234
- Inspira Air$234
- TruDi Probe$234
- ACell$222
- CONNECTED OR CART$213
- TEPEZZA$194
- PROPEL$161
How this compares
$62,971 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 29 | $660 |
| Ipratropium Bromide | 24 | $560 |
| Doxycycline Hyclate | 26 | $314 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $107 |
| Cephalexin | 12 | $61 |
| Ondansetron OdtOndansetron | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in la Jolla
- Brian WeeksSan Diego$924K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
- Todd MillerNewport Beach$259K
- Jeffrey SuhLos Angeles$223K
- Dennis TangLos Angeles$209K
- Jeffrey FeinfieldThousand Oaks$160K
- Jonathan SykesGranite Bay$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.